List of Small Molecule Pharmaceuticals Companies in Arizona - 10

Calviri’s mission is to provide affordable products worldwide that will end deaths from cancer. We are a fully integrated healthcare company developing a broad spectrum of vaccines and companion diagnostics that prevent and treat cancer for those either at risk or diagnosed. We focus on using frameshift neoantigens derived from errors in RNA processing to provide pioneering products against cancer. The company is a spin out of the Biodesign Institute, Arizona State University, located in Phoenix, AZ. We have the largest dog vaccine trial in the world underway at three premier veterinary universities. The five-year trial will assess the performance of a preventative cancer vaccine. For more information, please visit www.calviri.com.

Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company’s marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat severe recalcitrant acne; Targadox, an oral doxycycline drug for adjunctive therapy for severe acne; Ximino, an oral minocycline drug for the treatment of moderate to severe acne; and Exelderm cream and solution for topical use. It also sells doxycycline hyclate tablets, minocycline hydrocholoride capsules, and sulconazole nitrate cream and solution. The company was formerly known as Coronado Dermatology, Inc. and changed its name to Journey Medical Corporation. Journey Medical Corporation was incorporated in 2014 and is headquartered in Scottsdale, Arizona.

NuvOx Pharma is a biotechnology company based in Tucson, Arizona that is developing a first-in-class oxygen therapeutic to treat life-threatening diseases where hypoxia plays a role. Over 30 animal studies have shown therapeutic effect in seven different indications. Phase Ib/II clinical trials in stroke and oncology demonstrated safety and evidence of efficacy, and the company is preparing to run a Phase IIa trial in COVID-19 patients with Acute Hypoxemic Respiratory Failure (AHRF).

Quantum BioPharma is at the forefront of biotechnology, committed to advancing scientific innovation and transforming lives. Our groundbreaking research is dedicated to the development of life-saving treatments for neurodegenerative diseases, with a focus on Multiple Sclerosis (MS). Through our unwavering commitment to excellence, we are pioneering the development of Lucid-MS, a potential therapeutic aimed at remyelinating neurons in the brain and spinal cord. Our vision is to restore abilities and improve the quality of life for those affected by MS. As we advance our compounds through rigorous preclinical and clinical phases, we remain steadfast in our mission to turn scientific breakthroughs into reality. Join us in our pursuit of a brighter, healthier future, where innovation meets hope, and science saves lives.

PriZm Therapeutics is a late-stage clinical biotech company developing therapies for ultra-rare pediatric orphan diseases.

Reglagene is a therapeutics company that leverages its expertise in the design and development of brain penetrant medicines to create breakthrough therapies.

Snyder Biomedical Corporation was incorporated in 2008 by Robert W. Snyder, MD, PhD, an ophthalmologist and cell biologist, and John A. Martens.

Sonoran Biosciences is a preclinical-stage pharmaceutical company that develops antibacterial gel for the treatment of surgical site infection.

SDC delivers top-tier clinical trial services to pharmaceutical, biologic, and medical device/diagnostic companies since 2005. With industry leading strategic consulting and clinical biometrics solutions expertise at our core, our technology enabled services are fully scalable and supported via our diverse and complementary strategic partnerships to provide full service clinical trial solutions. Speak with us today to see why SDC Empowers Clinical Decisions.

Tesis Biosciences’ unique integrated medical platform is revolutionizing targeted genetic sequencing. Precision-based medicine to help treat major chronic diseases. Our mission is to change medicine by providing physicians, hospitals, and researchers with the tools to help patients treat and overcome major chronic conditions such as heart and lung disease, cancer, diabetes, and Alzheimer’s through advanced genetic testing. Through our collaborative efforts utilizing our unique processes, we help medical device and pharmaceutical companies bring to market products that improve the quality of life for patients.